BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarová J, Pokorná A, Klugar M, Riad A. Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers. Front Public Health 2022;10:896343. [PMID: 35651866 DOI: 10.3389/fpubh.2022.896343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Uhegwu CC, Abiodun OE, Haruna UA, Younes B, Moussaouli B, Odey GO. Achieving COVID‐19 herd immunity in Algeria: Current state of vaccination, challenges, and recommendations. Public Health Challenges 2023;2. [DOI: 10.1002/puh2.76] [Reference Citation Analysis]
2 Duijster JW, Lieber T, Pacelli S, Van Balveren L, Ruijs LS, Raethke M, Kant A, Van Hunsel F. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature. Front Immunol 2023;14:1078736. [PMID: 36793715 DOI: 10.3389/fimmu.2023.1078736] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shafie MH, Antony Dass M, Ahmad Shaberi HS, Zafarina Z. Screening and confirmation tests for SARS-CoV-2: benefits and drawbacks. Beni Suef Univ J Basic Appl Sci 2023;12:6. [PMID: 36647397 DOI: 10.1186/s43088-023-00342-3] [Reference Citation Analysis]
4 Engdaw GT, Worede EA, Destaw Bitew B. The Practice of Post-vaccination COVID-19 Prevention Strategy Among Healthcare Professionals in Felege Hiwot Referral Hospital, Northwest Ethiopia. Environ Health Insights 2022;16:11786302221146892. [PMID: 36601521 DOI: 10.1177/11786302221146892] [Reference Citation Analysis]
5 Nassar RI, Barakat M, Thiab S, El-Hajji F, Barqawi H, El-Huneidi W, Basheti IA, Abu-Gharbieh E. Web-Based Reporting of Post-Vaccination Symptoms for Inactivated COVID-19 Vaccines in Jordan: A Cross-Sectional Study. Vaccines (Basel) 2022;11. [PMID: 36679889 DOI: 10.3390/vaccines11010044] [Reference Citation Analysis]
6 Riad A, Alsaad SS, Almurikhi AA, Alzahrani FA, Alghamdi AM, Alzaid EH, Klugar M. Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA. Vaccines (Basel) 2022;10. [PMID: 36560547 DOI: 10.3390/vaccines10122137] [Reference Citation Analysis]
7 Hamimes A, Aouissi HA, Ababsa M, Lounis M, Jayarajah U, Napoli C, Kasemy ZA. The Effect of Preventive Measures and Vaccination against SARS-CoV-2 on the Infection Risk, Treatment, and Hospitalization: A Cross-Sectional Study of Algeria. Viruses 2022;14. [PMID: 36560775 DOI: 10.3390/v14122771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zare Z, Assarroudi A, Armat MR, Laal Ahangar M, Estaji M, MoghaddamHosseini V, Dianatinasab M. Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines: A Prospective Cohort Study. Life (Basel) 2022;12. [PMID: 36556411 DOI: 10.3390/life12122046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Al-Matouq JA, Ali MD, Al-Somali SM, Ahmad A, Banu N, Patel M. Prevalence of side-effects associated with the booster dose of Pfizer-BioNTech (BNT162b2) of COVID-19 Vaccine among vaccinated adults in the Eastern province of Saudi Arabia. Infect Prev Pract 2022;4:100251. [PMID: 36276167 DOI: 10.1016/j.infpip.2022.100251] [Reference Citation Analysis]
10 Cheng Y, Li T, Zhou YH. Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable. Hum Vaccin Immunother 2022;18:2099163. [PMID: 35930374 DOI: 10.1080/21645515.2022.2099163] [Reference Citation Analysis]
11 Poulakou G, Barakat M, Israel RJ, Bacci MR; Virazole Collaborator Group for COVID-19 Respiratory Distress. Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial. Clin Transl Sci 2023;16:165-74. [PMID: 36326174 DOI: 10.1111/cts.13436] [Reference Citation Analysis]
12 Lounis M, Aouissi HA, Abdelhadi S, Rais MA, Belkessa S, Bencherit D. Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population. Vaccines (Basel) 2022;10. [PMID: 36366290 DOI: 10.3390/vaccines10111781] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Khan J, Rasmi Y, Kırboğa KK, Ali A, Rudrapal M, Patekar RR. Development of gold nanoparticle-based biosensors for COVID-19 diagnosis. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00293-1] [Reference Citation Analysis]
14 Tondo G, Virgilio E, Naldi A, Bianchi A, Comi C. Safety of COVID-19 Vaccines: Spotlight on Neurological Complications. Life 2022;12:1338. [DOI: 10.3390/life12091338] [Reference Citation Analysis]
15 Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, Romanovskaya-romanko EA, Stukova MA, Isaev AA, Krasilnikov IV. SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study. Vaccines 2022;10:1290. [DOI: 10.3390/vaccines10081290] [Reference Citation Analysis]
16 Aouissi HA, Hamimes A, Ababsa M, Bianco L, Napoli C, Kebaili FK, Krauklis AE, Bouzekri H, Dhama K. Bayesian Modeling of COVID-19 to Classify the Infection and Death Rates in a Specific Duration: The Case of Algerian Provinces. IJERPH 2022;19:9586. [DOI: 10.3390/ijerph19159586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Liu M, Li Y. Advances in COVID-19 Vaccines and New Coronavirus Variants. Front Med (Lausanne) 2022;9:888631. [PMID: 35872788 DOI: 10.3389/fmed.2022.888631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Dziedzic A, Issa J, Hussain S, Tanasiewicz M, Wojtyczka R, Kubina R, Konwinska MD, Riad A. COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study. Front Public Health 2022;10:938067. [DOI: 10.3389/fpubh.2022.938067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
19 Aouissi HA, Kechebar MSA, Ababsa M, Roufayel R, Neji B, Petrisor AI, Hamimes A, Epelboin L, Ohmagari N. The Importance of Behavioral and Native Factors on COVID-19 Infection and Severity: Insights from a Preliminary Cross-Sectional Study. Healthcare (Basel) 2022;10. [PMID: 35885867 DOI: 10.3390/healthcare10071341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]